Sign In
Buy KOP
$43.09
+0.610 (+1.44%)
At Close: Jun 03, 2026
Gold eases as dollar extends rally; U.S.-China ties in focus
05:15am, Monday, 10'th Aug 2020
Gold prices edged lower on Monday and retreated sharply from a record peak in the last session, as the dollar made further gains with investors keeping a cautious eye on the U.S.-China spat ahead of k
Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights
12:00am, Monday, 10'th Aug 2020
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and co
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2020 Results - Earnings Call Transcript
05:23pm, Sunday, 09'th Aug 2020
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Allen Baharaff - President and CEO Dr.
Regional News Briefs
05:28am, Sunday, 09'th Aug 2020
Voters in Trinidad and Tobago will head to the polls tomorrow to elect a new government following an election campaign severely hampered by the coronavirus pandemic...
Upcoming Indices Dividend Drop Points
12:00am, Sunday, 09'th Aug 2020
Shares Analysis by CMC Markets covering: Vodafone Group PLC. Read CMC Markets's latest article on Investing.com UK.
Orchard Therapeutics plc (ORTX) CEO Bobby Gaspar on Q2 2020 Results - Earnings Call Transcript
07:32pm, Saturday, 08'th Aug 2020
Orchard Therapeutics plc (NASDAQ:ORTX) Q2 2020 Results Conference Call August 06, 2020 08:00 AM ET Company Participants Renee Leck - Investor Relations Bobby Gaspar - Chief Executive Officer Frank Tho
Celyad Oncology's (CYAD) CEO Filippo Petti on First Half 2020 Results - Earnings Call Transcript
02:07pm, Saturday, 08'th Aug 2020
Celyad Oncology SA (NASDAQ:CYAD) First Half 2020 Earnings Conference Call August 07, 2020 8:00 AM ET Company Participants Filippo Petti – Chief Executive Officer David Gilham – Chief Scientific Of
Nucor Excels On Costs And Is Using Its Efficiency As A Strategic Weapon (NYSE:NUE)
09:38pm, Friday, 07'th Aug 2020
Nucor had an impressive EBITDA beat, as the company did a good job of reducing costs and saw a comparatively healthier demand for higher-value products used in end-markets like construction.
Editas Medicine, Inc. (EDIT) Q2 2020 Earnings Call Transcript | The Motley Fool
07:31pm, Friday, 07'th Aug 2020
EDIT earnings call for the period ending June 30, 2020.
Kim Jong-un sends nuclear warning to US with promotion of military hardliner - expert
05:23pm, Friday, 07'th Aug 2020
KIM JONG-UN's apparent promotion of military hardliner sends a message to the United States in advance of November's Presidential election that the Hermit State must now be taken seriously as a nuclea
StratEdge White Paper, “Eutectic Die Attach Optimizes High Power GaN Devices,” is Now Available
12:00am, Thursday, 06'th Aug 2020
StratEdge announces a new white paper is available which discusses assembly methods to optimize GaN device’s efficiency, performance, and reliability.
Koppers Holdings Inc. Reports Second Quarter 2020 Results
12:00pm, Wednesday, 05'th Aug 2020
Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals and carbon compounds, today reported net income attributable to Koppers for the seco
Stunned by gold's record rise? There's more to come, analysts say
12:00am, Wednesday, 05'th Aug 2020
Stunned by gold's record rise? There's more to come, analysts say
Provention Bio: Undervalued And Overlooked Biotech Company - Diabetes Is Not Going Away Anytime Soon (NASDAQ:PRVB)
02:10pm, Tuesday, 04'th Aug 2020
Teplizumab's At-Risk PHASE II trial showed promising results in significantly delaying the onset of T1D in pre-symptomatic patients by a median of three years relative to placebo.
IPO Update: Freeline Therapeutics Proposes Terms For U.S. IPO (Pending:FRLN)
05:44pm, Monday, 03'rd Aug 2020
Freeline Therapeutics Holdings plc has filed to raise $125 million in a U.S. IPO.
